The resistance of different cancer cells to apoptosis is frequently facilitated by the inactivation of important apoptotic regulators, such as p53, and the overexpression of key anti-apoptotic proteins like Bcl-2 (Kollek et al., 2016; Opferman, 2007). This evidence concerns the gene TP53 and cancer.